reviewSchizophrenia BulletinDec 20, 2014BRONZE OA

Treatments of Negative Symptoms in Schizophrenia: Meta-Analysis of 168 Randomized Placebo-Controlled Trials

King's College London · South London and Maudsley NHS Foundation Trust · +2 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

Objectives

Existing treatments for schizophrenia can improve positive symptoms, but it is unclear if they have any impact on negative symptoms. This meta-analysis was conducted to assess the efficacy of available treatments for negative symptoms in schizophrenia.

Methods

All randomized-controlled trials of interventions for negative symptoms in schizophrenia until December 2013 were retrieved; 168 unique and independent placebo-controlled trials were used. Negative symptom scores at baseline and follow-up, duration of illness, doses of medication, type of interventions, and sample demographics were extracted. Heterogeneity was addressed with the I (2) and Q statistic. Standardized mean difference in values of the Negative Symptom Rating Scale used in each study was calculated as the main outcome measure.

Citation impact

694
total citations
FWCI
24.17
Percentile
100%
References
68
Citations per year

Authors

7

Topics & keywords

Keywords
  • Placebo
  • Randomized controlled trial
  • Medicine
  • Schizophrenia (object-oriented programming)
  • Meta-analysis
  • Internal medicine
  • Scale for the Assessment of Negative Symptoms
  • Clinical Global Impression
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.

Funding